drugset / Trial / NCT00184652

Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease

NCT00184652

Phase 2 Completed 140 enrolled Novo Nordisk A/S
RandomizedParallel-groupDouble-blindTreatment

Summary

This trial is conducted in Asia, Europe, and Middle East. Adult patients with chronic kidney disease are treated with growth hormone to assess effect on nutritional status.

Timeline

Start
2003-04
Primary completion
2005-09
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic 20 ug/kg
Subject Somatropin Protein / enzyme biologic 35 ug/kg
Subject Somatropin Protein / enzyme biologic 50 ug/kg